Supriya Lifescience P/B Ratio
Supriya Lifescience (SUPRIYA) P/B ratio is 5.62 (High), book value per share ₹748.75 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see SUPRIYA share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SUPRIYA P/B Ratio — Valuation Insights & Book Value Analysis
Supriya Lifescience price-to-book ratio interpretation, valuation status and historical context — current P/B 5.62 (High). View SUPRIYA 52-week chart for the annual high/low range and current price position.
- Stock appears overvalued with PB of 5.62, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 449.9% above historical average
- Trading at premium to sector average PB of -0.31
Supriya Lifescience P/B Ratio Historical Trend
SUPRIYA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review SUPRIYA P/E comparison to evaluate earnings-based valuation against sector peers.
SUPRIYA Historical P/B Ratio — Book Value Per Share & Year-End Price
Supriya Lifescience annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.12 | ₹748.75 | ₹840.50 | ₹1,198 | Moderate |
| 2025 | 1.21 | ₹623.12 | ₹751.50 | ₹997 | Moderate |
| 2024 | 1.45 | ₹509.38 | ₹739.80 | ₹815 | Moderate |
| 2023 | 0.72 | ₹437.5 | ₹314.75 | ₹700 | Low |
| 2022 | 0.61 | ₹385.0 | ₹235.05 | ₹616 | Low |
SUPRIYA vs Healthcare Peers — P/B Ratio Comparison
Supriya Lifescience P/B 5.62 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |